Corcept Therapeutics
CORT
#1631
Rank
โ‚ฌ11.69 B
Marketcap
108,15ย โ‚ฌ
Share price
2.24%
Change (1 day)
69.66%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of June 2026 : โ‚ฌ8.4 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is โ‚ฌ8.4 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚ฌ5.19 M-22%
2024-12-31โ‚ฌ6.66 M4779.61%
2023-12-31โ‚ฌ0.13 M-87.18%
2022-12-31โ‚ฌ1.06 M129.42%
2021-12-31โ‚ฌ0.46 M-77.61%
2020-12-31โ‚ฌ2.07 M-32.87%
2019-12-31โ‚ฌ3.08 M
2018-12-31N/A
2016-12-31โ‚ฌ13.94 M1.86%
2015-12-31โ‚ฌ13.68 M76.63%
2014-12-31โ‚ฌ7.74 M86.33%
2013-12-31โ‚ฌ4.15 M107.58%
2012-12-31โ‚ฌ2 M
2010-12-31N/A-100%
2009-12-31โ‚ฌ0 M-63.41%
2008-12-31โ‚ฌ0.01 M-42.38%
2007-12-31โ‚ฌ0.01 M-37.6%
2006-12-31โ‚ฌ0.03 M-30.17%
2005-12-31โ‚ฌ0.04 M
2003-12-31โ‚ฌ0.41 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ43.75 B 520,396.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ43.74 B 520,163.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ56.39 B 670,678.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ48.99 B 582,725.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ48.10 B 572,089.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ40.20 B 478,118.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ0.29 B 3,411.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ0.22 B 2,581.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ3.75 B 44,504.61%๐Ÿ‡บ๐Ÿ‡ธ USA